Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Doximity, Inc. (DOCS) Q1 2025 Earnings Call Transcript
08:46pm, Thursday, 08'th Aug 2024
Start Time: 17:00 January 1, 0000 5:50 PM ET Doximity, Inc. (NYSE:DOCS ) Q1 2025 Earnings Conference Call August 08, 2024, 17:00 PM ET Company Participants Jeff Tangney - Co-founder and CEO Nate Gross
Doximity (DOCS) Q1 Earnings and Revenues Surpass Estimates
06:25pm, Thursday, 08'th Aug 2024
Doximity (DOCS) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.
Gear Up for Doximity (DOCS) Q1 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 05'th Aug 2024
Beyond analysts' top -and-bottom-line estimates for Doximity (DOCS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarte
Why the Market Dipped But Doximity (DOCS) Gained Today
07:20pm, Tuesday, 30'th Jul 2024
Doximity (DOCS) closed the most recent trading day at $28.66, moving +1.49% from the previous trading session.
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
11:11am, Friday, 26'th Jul 2024
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most.
Dr Martens targets growth in US direct-to-customer market
03:32am, Thursday, 11'th Jul 2024
Dr Martens PLC (LSE:DOCS) has published a bare trading update prior to a Thursday AGM. The classic British footwear company said that “trading since the start of this financial year has been in lin
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
07:20pm, Friday, 28'th Jun 2024
Doximity (DOCS) closed the most recent trading day at $27.97, moving +0.5% from the previous trading session.
Dr Martens rating could go either way, depending on US consumer demand - analyst
09:00am, Thursday, 20'th Jun 2024
Dr Martens PLC (LSE:DOCS) stock market rating is on something of a knife edge with analysts at Barclay's keen for visibility over the boot maker's direct-to-consumer sales channel. A less than emphati
NEW YORK, June 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on b
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS
12:00pm, Monday, 17'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS). Such investors are advi
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:20am, Monday, 17'th Jun 2024
LOS ANGELES--(BUSINESS WIRE)--DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
FINAL DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!
05:00am, Monday, 17'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. (
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and Apri
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:20am, Friday, 14'th Jun 2024
LOS ANGELES--(BUSINESS WIRE)--DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
10:00am, Friday, 14'th Jun 2024
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors
